AccessClosure announces distribution agreement for the FLASH Ostial System
Published on: October 16, 2013

AccessClosure, Inc., the market leader in extravascular closure devices, announced today an exclusive agreement with Ostial Corporation to distribute the Flash Ostial System Dual Balloon Angioplasty Catheter in the United States. The Flash Ostial System is designed to help overcome the challenges of aorto-ostial stenting and compliments the Mynx® Product Family of Vascular Closure Devices to expand AccessClosure’s portfolio.

“AccessClosure is well-positioned to add relevant and useful products to our portfolio due to the strong relationships of our sales team with interventional cardiologists, vascular surgeons, and interventional radiologists through the sale of Mynx,” said Gregory D. Casciaro, President and CEO of AccessClosure. “As a customer-focused company, we strive to provide innovative technologies such as Mynx and Flash for superb clinical outcomes. Including the Flash Ostial System in our portfolio allows AccessClosure to increase our level of service and education to healthcare providers.”

Ostial lesions are a challenging area for treatment. According to Richard Kovach, M.D., Chair, Interventional Cardiology and Director, Cardiac Catheterization Laboratory at Deborah Heart and Lung Center, in Browns Mills, NJ, “The dual balloon design of the Flash Ostial System is an exciting treatment option for ostial disease.Flash conforms to the ostium to enable excellent stent apposition, which is important for coverage of the disease and for preserving reaccess to the treated vessel.” Dr. Kovach has been using the Flash Ostial System in his practice for the past year.

“AccessClosure is the ideal partner to distribute the Flash device,” said Yi Yang, Chief Operating Officer of Ostial Corporation. “Their sales team understands the importance of bringing innovative products to market that offer a clinical benefit.”

AccessClosure will showcase its growing portfolio of devices at booth 314 at the Vascular Interventional Advances 2013 (VIVA) this week in Las Vegas, NV, beginning Tuesday when the exhibit hall opens at the Wynn Hotel.

Related Content

TAVR linked to lower stroke risk than SAVR in patients with AS and cardiogenic shock
PAD patients face greater risk of death, complications after a heart attack
SCAI 2024 Scientific Sessions to focus on TAVR, PAD and other key trends in interventional cardiology
Cardiologist details the many health disparities he encounters in rural Mississippi
FDA approves Abbott’s resorbable stent for BTK arteries
FDA clears new catheter for peripheral blood clots

Around the web

Health Imaging
New imaging protocols proposed to curb rise of cardiovascular infections

Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.

Radiology Business
What does radiology have to do with climate change?

Kate Hanneman, MD, explains why many vendors and hospitals want to lower radiology's impact on the environment. "Taking steps to reduce the carbon footprint in healthcare isn’t just an opportunity," she said. "It’s also a responsibility."

Radiology Business
Philips launches new AI-enabled CT scanner aimed at cardiology at ECR 2024

Philips introduced a new CT system at ECR aimed at the rapidly growing cardiac CT market, incorporating numerous AI features to optimize workflow and image quality.

Design by Adaptive Theme
Trimed Popup
Trimed Popup